• Carbenoxolone disodium: Protocol and QC Guide

  2026-08-20

  Carbenoxolone disodium (SKU A8389) is a research tool for perturbing 11β-hydroxysteroid dehydrogenase activity, gap junction communication, and related glucocorticoid signaling in cell and tissue workflows. This guide emphasizes formulation, controls, and interpretation boundaries; it does not support in vivo efficacy claims or conclusions about pathway selectivity without orthogonal validation.

• GSK2606414: Reading PERK-Driven Cell Fate

  2026-08-20

  GSK2606414 is a selective PERK inhibitor for resolving how ER stress becomes inflammatory cell death. This article translates recent nucleus pulposus cell findings into a causal assay strategy while defining what pharmacological inhibition can—and cannot—establish.

• AL-8810: Prostaglandin F2α Antagonist Workflows

  2026-08-19

  AL-8810 provides a receptor-focused way to separate FP receptor activity from broader prostanoid synthesis effects. Its use spans smooth muscle, ocular, vascular, and endometrial models, enabling linked measurements of ERK1/2 signaling, MMP-2 secretion, vascular remodeling, and tissue breakdown.

• RNA Pol II Loss Triggers Apoptosis Beyond Transcription

  2026-08-19

  Harper and colleagues show that RNA polymerase II inhibition kills cells through an active apoptotic signaling response rather than through passive loss of transcriptional output. Their identification of the Pol II degradation-dependent apoptotic response (PDAR) provides a framework for interpreting how transcription-targeting and other anticancer drugs can converge on mitochondrial cell death.

• Lithium, Exosomal Wnt10a, and Bone Formation

  2026-08-18

  This study identifies a mechanistic link between lithium treatment, Rab11a-dependent exosomal Wnt10a secretion, and β-catenin activation in bone mesenchymal stem cells. Its comparison of lithium-engineered exosomes and GelMA hydrogel delivery provides a framework for improving cell-free strategies for bone regeneration while highlighting important translational questions about dose, cargo consistency, and model transferability.

• Atrial Natriuretic Peptide (ANP) Rat: Research Guide

  2026-08-18

  Atrial Natriuretic Peptide is an ANP peptide hormone used to investigate natriuresis, vasodilation, fluid balance, and adipose metabolism. Product specifications support cardiovascular research, but the supplied dossier contains a sequence-length discrepancy that should be resolved before sequence-dependent experiments.

• UBR1 and UBR2: Mammalian ER Stress Sensors

  2026-08-17

  The reference study identifies the E3 ligases UBR1 and UBR2 as mammalian N-recognins that connect the N-degron pathway with ER stress adaptation. Its findings show that stress-dependent stabilization of these proteins supports protein quality control, whereas their loss increases susceptibility to ER stress-induced apoptosis.

• Cimetidine in BBB Permeability Workflows

  2026-08-17

  Cimetidine offers a practical test compound for linking H2 receptor pharmacology with transporter-aware barrier assays. This guide adapts a high-throughput LLC-PK1-MOCK/MDR1 workflow for permeability screening while separating brain-distribution questions from gastrointestinal cancer research claims.

• Cyclic di-GMP Workflows for Biofilm and STING Research

  2026-08-16

  Cyclic di-GMP enables temporally controlled studies of biofilm persistence, genome stability, and STING-driven innate immunity. This practical guide connects the molecule’s bacterial antitoxin function with immune modulation research while emphasizing aqueous formulation, assay controls, and troubleshooting.

• Laminin (925-933) and the Next ECM Translation

  2026-08-15

  Laminin (925-933) offers a defined way to interrogate laminin receptor biology across adhesion, chemotaxis, and engineered extracellular matrix models. This thought-leadership perspective connects its established cell-based activity with collagen-VI-enriched islet organoid research while clearly separating validated evidence from translational hypotheses.

• Eicosapentaenoic Acid (EPA) in Cell Assays

  2026-08-14

  This scenario-based guide explains how Eicosapentaenoic Acid (EPA), SKU B3464, can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing biological effects with formulation or assay artifacts. It covers concentration selection, solvent controls, interpretation, and practical product-selection criteria for reproducible cardiovascular disease research.

• Lamotrigine: Assay Design Beyond Channel Blockade

  2026-08-14

  Lamotrigine research is strengthened when direct sodium-channel effects are separated from matrix, exposure, and biotransformation variables. This guide translates metabolic-assay lessons into practical designs for neurological and cardiac experiments.

• Betaine Hydrochloride as an Assay Control Variable

  2026-08-13

  Explore how Betaine hydrochloride can be managed as a physicochemical control variable in enzyme, protease, cell-based, and molecular biology assays. This evidence-aware framework connects reagent handling with the multi-layered inflammation analysis reported in esophageal cancer research.

• CP-673451: Translating PDGFR Selectivity in Glioma

  2026-08-13

  A translational analysis of CP-673451 as a selective PDGFRα/β inhibitor, connecting pathway biology, ATRX-deficient glioma sensitivity, angiogenesis assays, xenograft validation, and biomarker-led experimental strategy.

• Dual-Readout mRNA for Translational Delivery Science

  2026-08-12

  A thought-leadership guide to using dual fluorescent and bioluminescent readouts to separate mRNA delivery, intracellular trafficking, stability, and functional translation. The article positions EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) as a strategic reporter for optimizing carriers and making translational decisions.

16575 records 1/1105 page Next 12345 下5页 Last page